FR2675146B1 - - Google Patents

Info

Publication number
FR2675146B1
FR2675146B1 FR9104339A FR9104339A FR2675146B1 FR 2675146 B1 FR2675146 B1 FR 2675146B1 FR 9104339 A FR9104339 A FR 9104339A FR 9104339 A FR9104339 A FR 9104339A FR 2675146 B1 FR2675146 B1 FR 2675146B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9104339A
Other languages
French (fr)
Other versions
FR2675146A1 (fr
Inventor
Luc Devocelle
Philippe Mackiewicz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR9104339A priority Critical patent/FR2675146A1/fr
Priority to HU9902345A priority patent/HU220086B/hu
Priority to HU9201190A priority patent/HU212197B/hu
Priority to HU9902346A priority patent/HU220081B/hu
Priority to HU9503790A priority patent/HU217523B/hu
Priority to IE113092A priority patent/IE921130A1/en
Priority to EP92401002A priority patent/EP0508900B1/fr
Priority to JP11520192A priority patent/JP3172575B2/ja
Priority to DE69227478T priority patent/DE69227478T2/de
Publication of FR2675146A1 publication Critical patent/FR2675146A1/fr
Priority to US07/974,484 priority patent/US5310896A/en
Priority to US08/190,881 priority patent/US5434258A/en
Priority to US08/372,647 priority patent/US5451690A/en
Application granted granted Critical
Publication of FR2675146B1 publication Critical patent/FR2675146B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0092—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR9104339A 1991-04-10 1991-04-10 Nouveaux derives sterouides de la pregna-1,4-diene-3,20-dione, leur preparation, leur application a la preparation de derives 16,17-methylene dioxy substitues et nouveaux intermediaires. Granted FR2675146A1 (fr)

Priority Applications (12)

Application Number Priority Date Filing Date Title
FR9104339A FR2675146A1 (fr) 1991-04-10 1991-04-10 Nouveaux derives sterouides de la pregna-1,4-diene-3,20-dione, leur preparation, leur application a la preparation de derives 16,17-methylene dioxy substitues et nouveaux intermediaires.
HU9201190A HU212197B (en) 1991-04-10 1992-04-08 Process for producing pregna-1,4-diene-3,20-dione derivatives
HU9902346A HU220081B (hu) 1991-04-10 1992-04-08 Pregna-1,4-dién-3,20-dion-származékok és eljárás előállításukra
HU9503790A HU217523B (hu) 1991-04-10 1992-04-08 Pregna-1,4-dién-3,20-dion-származékok és eljárás az előállításukra
HU9902345A HU220086B (hu) 1991-04-10 1992-04-08 Pregna-1,4-dién-3,20-dion-származékok és eljárás előállításukra
EP92401002A EP0508900B1 (fr) 1991-04-10 1992-04-09 Nouveaux dérivés stéroides de la pregna-1,4-dièn-3,20-dione, leur préparation, leur application à la préparation de dérivés 16,17-méthylène dioxy substitués et nouveaux intermediaires
IE113092A IE921130A1 (en) 1991-04-10 1992-04-09 New steroid derivatives of pregna-1,4-diene-3,20-dione,¹their preparation, their use in the preparation of¹substituted 16,17-methylene dioxy derivatives and new¹intermediates
JP11520192A JP3172575B2 (ja) 1991-04-10 1992-04-09 プレグナ−１，４−ジエン−３，２０−ジオンのステロイド誘導体の製造法及びその中間体
DE69227478T DE69227478T2 (de) 1991-04-10 1992-04-09 Neue Steroidderivate vom Typ Pregna-1,4-diene-3,20-dion, ihre Herstellung und Verwendung zur Herstellung der substituierten 16,17-Methylendioxyderivate und neuen Zwischenprodukten
US07/974,484 US5310896A (en) 1991-04-10 1992-11-12 Process for preparing Δ1,4 -pregnadiene-3,20-diones
US08/190,881 US5434258A (en) 1991-04-10 1994-02-02 δ1,4 -pregnadiene-3,20-diones
US08/372,647 US5451690A (en) 1991-04-10 1995-01-13 Lambda-1,4-pregnadiene-3,20-diones

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9104339A FR2675146A1 (fr) 1991-04-10 1991-04-10 Nouveaux derives sterouides de la pregna-1,4-diene-3,20-dione, leur preparation, leur application a la preparation de derives 16,17-methylene dioxy substitues et nouveaux intermediaires.

Publications (2)

Publication Number Publication Date
FR2675146A1 FR2675146A1 (fr) 1992-10-16
FR2675146B1 true FR2675146B1 (enExample) 1995-03-24

Family

ID=9411660

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9104339A Granted FR2675146A1 (fr) 1991-04-10 1991-04-10 Nouveaux derives sterouides de la pregna-1,4-diene-3,20-dione, leur preparation, leur application a la preparation de derives 16,17-methylene dioxy substitues et nouveaux intermediaires.

Country Status (7)

Country Link
US (3) US5310896A (enExample)
EP (1) EP0508900B1 (enExample)
JP (1) JP3172575B2 (enExample)
DE (1) DE69227478T2 (enExample)
FR (1) FR2675146A1 (enExample)
HU (1) HU212197B (enExample)
IE (1) IE921130A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2675146A1 (fr) * 1991-04-10 1992-10-16 Roussel Uclaf Nouveaux derives sterouides de la pregna-1,4-diene-3,20-dione, leur preparation, leur application a la preparation de derives 16,17-methylene dioxy substitues et nouveaux intermediaires.
GB9423919D0 (en) * 1994-11-26 1995-01-11 Rhone Poulenc Rorer Ltd Chemical process
CN1209138A (zh) * 1995-12-20 1999-02-24 先灵公司 9,11β－环氧甾族化合物的制备方法
IT1291288B1 (it) 1997-04-30 1999-01-07 Farmabios Srl Processo per la preparazione di 16,17 acetali di derivati pregnanici con controllo della distribuzione epimerica al c-22.
US6266556B1 (en) 1998-04-27 2001-07-24 Beth Israel Deaconess Medical Center, Inc. Method and apparatus for recording an electroencephalogram during transcranial magnetic stimulation
IT1302657B1 (it) * 1998-10-13 2000-09-29 Farmabios Srl Processo stereoselettivo per la preparazione di budesonide nella formadi epimero 22-r.
WO2002038584A1 (en) 2000-11-10 2002-05-16 Altana Pharma Ag Process for the production of 16,17-[(cyclohexylmethylen)bis(oxy)]-11,21-dihydroxy-pregna-1,4-dien-3,20-dion or its 21-isobutyrat by transketalisation
DK2278978T3 (en) 2008-05-28 2015-09-21 Reveragen Biopharma Inc NON-HORMONAL STEROID MODULATORS OF NF-KB FOR TREATMENT OF DISEASE
US9198921B2 (en) 2010-04-05 2015-12-01 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
EP3250211B1 (en) * 2015-01-30 2021-12-22 Coral Drugs Pvt. Ltd. Novel process for preparation of glucocorticoid steroids
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990401A (en) * 1958-06-18 1961-06-27 American Cyanamid Co 11-substituted 16alpha, 17alpha-substituted methylenedioxy steroids
US2998433A (en) * 1960-07-22 1961-08-29 American Cyanamid Co 2alpha-halo-4, 9(11), 16-pregnatriene-3, 20-diones
US3047468A (en) * 1961-06-06 1962-07-31 American Cyanamid Co Method of preparing delta1, 4-3-keto steroids of the pregnane series
SE378109B (enExample) * 1972-05-19 1975-08-18 Bofors Ab
DE2360444A1 (de) * 1973-11-30 1975-06-05 Schering Ag Neue pregnansaeure-derivate
US3970646A (en) * 1974-04-24 1976-07-20 Ortho Pharmaceutical Corporation Halo-steroidal thioketals
US4124707A (en) * 1976-12-22 1978-11-07 Schering Corporation 7α-Halogeno-3,20-dioxo-1,4-pregnadienes, methods for their manufacture, their use as anti-inflammatory agents, and pharmaceutical formulations useful therefor
US4267173A (en) * 1979-11-05 1981-05-12 Schering Corporation Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor
DE3143757A1 (de) * 1981-10-30 1983-05-11 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue kortikoide, ihre herstellung und verwendung
SE8403905D0 (sv) * 1984-07-30 1984-07-30 Draco Ab Liposomes and steroid esters
SE8604059D0 (sv) * 1986-09-25 1986-09-25 Astra Pharma Prod A method of controlling the epimeric distribution in the preparation of 16,17-acetals of pregnane derivatives
HU203562B (en) * 1989-03-09 1991-08-28 Richter Gedeon Vegyeszet Process for producing new steroide diols and pharmaceutical compositions containing them
HU203769B (en) * 1989-03-09 1991-09-30 Richter Gedeon Vegyeszet Process for producing new steroide derivatives and pharmaceutical compositions containing them
FR2675146A1 (fr) * 1991-04-10 1992-10-16 Roussel Uclaf Nouveaux derives sterouides de la pregna-1,4-diene-3,20-dione, leur preparation, leur application a la preparation de derives 16,17-methylene dioxy substitues et nouveaux intermediaires.

Also Published As

Publication number Publication date
DE69227478T2 (de) 1999-06-02
DE69227478D1 (de) 1998-12-10
US5451690A (en) 1995-09-19
FR2675146A1 (fr) 1992-10-16
IE921130A1 (en) 1992-10-21
HUT61570A (en) 1993-01-28
HU212197B (en) 1996-03-28
US5434258A (en) 1995-07-18
JPH05170788A (ja) 1993-07-09
US5310896A (en) 1994-05-10
EP0508900B1 (fr) 1998-11-04
EP0508900A1 (fr) 1992-10-14
HU9201190D0 (en) 1992-07-28
JP3172575B2 (ja) 2001-06-04

Similar Documents

Publication Publication Date Title
TW215473B (enExample)
DE4290947T1 (enExample)
DE4290412T1 (enExample)
DE4290924T1 (enExample)
DE4292209T1 (enExample)
FR2675146B1 (enExample)
DE4291109T1 (enExample)
DE4290056T1 (enExample)
TW276326B (enExample)
ECSM91561U (enExample)
JPH0498067U (enExample)
ECSM91576U (enExample)
JPH0499038U (enExample)
ECSM91550U (enExample)
ECSDI910050S (enExample)
ECSDI910048S (enExample)
ECSDI910047S (enExample)
JPH0499076U (enExample)
ATA245291A (enExample)
JPH0495412U (enExample)
IN175937B (enExample)
JPH0498031U (enExample)
CN3009764S (enExample)
EP0541061A3 (enExample)
EP0500398A3 (enExample)

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name
TP Transmission of property
TP Transmission of property
ST Notification of lapse